<DOC>
	<DOCNO>NCT00706290</DOCNO>
	<brief_summary>RATIONALE : Providing cognitive-behavioral therapy ( CBT ) may reduce anxiety improve quality life patient advanced cancer . PURPOSE : To examine development pilot test brief cognitive-behavioral therapy intervention treat anxiety improve quality life patient advanced cancer . Hypothesis : Patients anxiety associate advanced cancer receive CBT report significantly few anxiety symptom compare comparison condition .</brief_summary>
	<brief_title>Brief CBT Anxiety Advanced Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To develop examine feasibility patient acceptability administer manualized cognitive-behavioral intervention improve quality life treat anxiety patient advance cancer . - To estimate effect size manualized cognitive-behavioral intervention reduce anxiety patient advance cancer . - To estimate effect size secondary outcome ( i.e. , depression quality life ) examine extent specific variable ( i.e. , sex , age , chemotherapy side effect , pain level ) consistent conceptual model potential moderator treatment effect . OUTLINE : This pilot study follow randomize study . Patients stratify accord type cancer . - Pilot study : Patients complete qualitative interview explore way anxiety impact patient , identify component cognitive-behavioral therapy intervention useful , determine optimal method delivery intervention ( e.g. , number timing intervention , administration chemotherapy infusion feasible ) . Based upon result full treatment manual write use randomize study . Patients randomize 1 2 treatment arm . - Arm I ( cognitive-behavioral therapy ) : Patients undergo six-seven 90-minute treatment session ( 2 month ) base result pilot study . Modules include psychoeducation goal setting ; relaxation training ; cognitive restructuring ; cop cancer fear ; activity planning pacing ; review , termination , plan continue use skill . - Arm II ( routine care ) : Patients receive routine medical care . At completion treatment , participant meet blinded independent assessor ass outcome . Patients undergo psychiatric evaluation , include Hamilton Anxiety Rating Scale ( HAM-A ) , Montgomery Asberg Depression Rating Scale ( MADRS ) , Mini International Neuropsychiatric Interview ( MINI ) , psychosocial self-reported battery baseline 2-3 month . After complete treatment , patient underwent routine care ( arm II ) may undergo cognitive-behavioral therapy arm I , desire .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>INCLUSION CRITERIA : Diagnosis incurable solid tumor cancer At least four week postdiagnosis Current symptom anxiety anxiety principal psychiatric problem Patients comorbid depression eligible long anxiety symptom primary Concurrent pharmacotherapy anxiety allow EXCLUSION CRITERIA : Delirium dementia Active untreated major psychiatric condition schizophrenia bipolar disorder , psychotic disorder , substance dependence Other inability complete informed consent process study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>anxiety</keyword>
	<keyword>depression</keyword>
	<keyword>quality life</keyword>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>advanced cancer</keyword>
	<keyword>metastatic cancer</keyword>
	<keyword>stage IV cancer</keyword>
	<keyword>cognitive behavioral therapy</keyword>
</DOC>